Where does AI fit in the therapeutics discovery equation?
The Keys to Success, As Told By Today’s Top Minds in Biotech, Pharma, and Healthcare
2022 Year in Review
Welcome to our AV Fellows Class of 2022!
ARTIS Ventures Pioneer Spotlight: Michael Yang
ARTIS Portfolio founders named to Forbes 30 Under 30 for Healthcare & Consumer Technology
ARTIS Ventures Pioneer Spotlight: Quita Highsmith
ARTIS Ventures Welcomes Henry Klingenstein to Its Investment Team
A Bold Effort to Cure HIV—Using Crispr
Health Tech startups are booming. These 11 VC investors are behind some of the hottest deals
Excision BioTherapeutics Doses First Participant in EBT-101 Phase 1/2 Trial
Ameena El-Bibany of ARTIS Ventures: 5 Things I Need To See Before Making A VC Investment
Power Exits Stealth with $7M to Ensure All Patients Have Access to Clinical Trials
Vertex to Acquire ViaCyte, With the Goal of Accelerating its Potentially Curative Programs in T1D
Mental Health Startup Meomind Launches to Improve Access to Therapy and Reduce Employee Burnout